ATC code V: Various |
---|
|
Other ATC codes |
ATC code V Various is a section of the Anatomical Therapeutic Chemical Classification System, a system of alphanumeric codes developed by the World Health Organization (WHO) for the classification of drugs and other medical products.
Codes for veterinary use (ATCvet codes) can be created by placing the letter Q in front of the human ATC code: for example, QV.
National issues of the ATC classification may include additional codes not present in this list, which follows the WHO version.
References
- "ATC (Anatomical Therapeutic Chemical Classification System) – Synopsis". National Institutes of Health. Retrieved 1 February 2020.
- World Health Organization. "Anatomical Therapeutic Chemical (ATC) Classification". World Health Organization. Retrieved 3 January 2022.
- "Structure and principles". WHO Collaborating Centre for Drug Statistics Methodology. 15 February 2018. Retrieved 3 January 2022.
- "ATC/DDD Index 2022: code V". WHO Collaborating Centre for Drug Statistics Methodology.
- "ATCvet Index 2022: code QV". WHO Collaborating Centre for Drug Statistics Methodology.
Major chemical drug groups – based upon the Anatomical Therapeutic Chemical Classification System | |
---|---|
gastrointestinal tract / metabolism (A) | |
blood and blood forming organs (B) | |
cardiovascular system (C) | |
skin (D) | |
genitourinary system (G) | |
endocrine system (H) | |
infections and infestations (J, P, QI) | |
malignant disease (L01–L02) | |
immune disease (L03–L04) | |
muscles, bones, and joints (M) | |
brain and nervous system (N) |
|
respiratory system (R) | |
sensory organs (S) | |
other ATC (V) | |
Antidotes (V03AB) | |||||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Nervous system |
| ||||||||||||||
Circulatory system |
| ||||||||||||||
Other |
| ||||||||||||||
Emetic | |||||||||||||||
|
Chelating agents / chelation therapy (V03AC, others) | |
---|---|
Copper | |
Iron | |
Lead | |
Thallium | |
Other | |
|
Drugs for treatment of hyperkalemia and hyperphosphatemia (V03AE) | |
---|---|
Potassium binders | |
Phosphate binders |
Detoxifying agents for chemotherapy treatment (V03AF) | |
---|---|
Folic acid / methotrexate |
|
Uric acid (TLS) | |
Acrolein / nitrogen mustards | |
Iron / anthracyclines | |
Alkylating agents | |
Keratinocyte growth factor | |
Other |
Other therapeutic products (V03AG–V03AZ) | |
---|---|
Treatment of hypercalcemia | |
Treatment of hypoglycaemia | |
Medical gases |
Contrast media (V08) | |||||||||||||
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
X-ray and CT |
| ||||||||||||
MRI |
| ||||||||||||
Ultrasound |
| ||||||||||||
|
Diagnostic radiopharmaceuticals (V09) | |||||
---|---|---|---|---|---|
Central nervous system | |||||
Skeletal system | |||||
Renal | |||||
Gastrointestinal/Hepatic | |||||
Respiratory system |
| ||||
Cardiovascular system | |||||
Inflammation/infection | |||||
Tumor | |||||
Adrenal cortex |
| ||||
Radionuclides (including tracers) |
| ||||
Isotopes used:
|
Therapeutic radiopharmaceuticals (V10) | |||||
---|---|---|---|---|---|
Pain palliation | |||||
Adrenergic tumors | |||||
CD20 antibodies | |||||
Radionuclides |
| ||||
Isotopes used:
|